DNA methylation and detection of cervical cancer and precancerous lesions using molecular methods
- 549 Downloads
Cervical cancer is the third most common cancer disease affecting the female population, and a key factor in the development of the disease is the human papillomavirus infection (HPV). The disease is also impacted by epigenetic changes such as DNA methylation, which causes activation or exclusion of certain genes. The aim of our review is to summarize and compare the most common molecular methods for detection of methylated promoter regions in biomarkers occurring in cervical carcinoma and also show the importance of connections of HR-HPV testing with methylation analysis in patients with cervical intraepithelial neoplasia. Insight into genetic and epigenetic alterations associated with cervical cancer development can offer opportunities for the molecular biomarkers that can be useful for screening, diagnosis, and also as new ways of treatment of cervical cancer precursor lesions.
KeywordsMethylation DNA HPV Cervical cancer
This work was supported by the project “Molecular diagnostics of cervical cancer” (ITMS:26220220113), Comenius University Grants 303/2011, 242/2012, 287/2015, 121/2015, and the VEGA Grant 1/0271/12 as well as the APVV-0224-12 grant.
Compliance with ethical standards
Conflicts of interest
- 1.Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer. GLOBOCAN, 2008.Google Scholar
- 2.Sung LC, et al. Methylation markers for diagnosis of cervical cancer, Patent application publication, 2013.Google Scholar
- 8.Culbova M, Lasabova Z, Stanclova A, et al. Metylácia vybraných tumor-supresorových génov v benígnych a malígnych ovariálnych nádoroch. Article in Czech. Česká gynekologie. 2011;76(4):274–9.Google Scholar
- 23.Fraga MF, Esteller M. DNA methylation: a profile of methods and applications. Biotechniques. 2002;33(4):6–49.Google Scholar